Preliminary results of a prospective randomized study of basiliximab in kidney transplantation.
Clinica Chirurgica Università di Roma "Tor Vergata", Rome, Italy.
F
F
Pisani
O
O
Buonomo
G
G
Iaria
G
G
Tisone
V
V
Mazzarella
S
S
Pollicita
C
C
Camplone
A
A
Piazza
M
M
Valeri
A
A
Famulari
C U
CU
Casciani
D000208:Acute Disease; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D005240:Feasibility Studies; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D011446:Prospective Studies; D011993:Recombinant Fusion Proteins; D014554:Urination
D000911:Antibodies, Monoclonal; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D008775:Methylprednisolone